Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | GQ1001 |
| Trade Name | |
| Synonyms | GQ-1001|GQ 1001|ADC GQ1001 |
| Drug Descriptions |
GQ1001 is an antibody-drug conjugate (ADC) consisting of trastuzumab and DM1 conjugated with a stable linker, which may lead to improved growth inhibition of ERBB2 (HER2)-expressing tumors (Cancer Res (2023) 83 (7_Supplement): 2702). |
| DrugClasses | HER2 (ERBB2) Antibody 79 HER2 (ERBB2) Antibody-Drug Conjugate 35 |
| CAS Registry Number | NA |
| NCIT ID | C173827 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| GQ1001 | GQ1001 | 0 | 1 |